The harms from other people’s alcohol consumption in Wales (Public Health Wales)
Bibliography: Interventions – Harm Reduction
The CUPID Project: Understanding and preventing hepatitis C transmission within heterosexual couples
Main findings and recommendations for policy and practice (UNSW, Australia)
Prevention of harm caused by alcohol exposure in pregnancy
Rapid review and case studies from Member States (WHO)
Taking away the chaos (PDF)
The health needs of people who inject drugs in public places in Glasgow city centre (NHS)
Understanding and preventing drug-related deaths
The report of a national expert working group to investigate drug-related deaths in England (Public Health England)
The health impacts of alcohol (PDF)
This factsheet provides an overview of how alcohol effects individuals’ health and also the population levels of alcohol related morbidity and mortality in the UK (IAS)
UK Chief Medical Officers’ Low Risk Drinking Guidelines (PDF)
At the request of the UK Chief Medical Officers (CMOs), three groups of independent experts met between 2013 and 2016 to consider the evidence on the health effects of alcohol and whether this could form the basis of new advice for the public (Department of Health, UK)
Alcohol CLeaR self-assessment tool
CLeaR provides a framework for strategic review and analysis of local structures and delivery focusing on local outcomes and priorities (Public Health England)
FDA Supports Greater Access to Naloxone to Help Reduce Opioid Overdose Death
One option to do this is identifying ways to assist manufacturers in submitting an application to the FDA for an over-the-counter (OTC) version of a naloxone product
A Healthier Start: Addressing Neonatal Abstinence Syndrome and Opioid Misuse during Pregnancy
In collaboration with partners across federal government, SAMHSA is sharpening its focus on opioid-dependent pregnant women. And with a $1 billion, two-year investment of new, mandatory funding in the President’s Fiscal Year (FY) 2017 Budget proposal to bolster our efforts, we’re expanding and intensifying our work to prevent and treat opioid dependence, including identification and treatment of NAS
New Psychoactive Substances (NPS) resource pack
A resource pack on new psychoactive substances for educators and practitioners working with young people (Home Office)
Hepatitis C among drug users in Europe: epidemiology, treatment and prevention
A state of the art review of the epidemiology of hepatitis C virus (HCV) infection in Europe and an overview of the way preventive measures are currently implemented in European countries set the scene (EMCDDA)
Families Affected by Parental Substance Use
The purposes of this clinical report are to review some of the short-term effects of maternal substance use during pregnancy and long-term implications of fetal exposure; describe typical medical, psychiatric, and behavioral symptoms of children and adolescents in families affected by substance use; and suggest proficiencies for pediatricians involved in the care of children and adolescents of families affected by substance use, including screening families, mandated reporting requirements, and directing families to community, regional, and state resources that can address needs and problems (Pediatrics)
Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization
Buprenorphine (often prescribed with naloxone, as “suboxone”) is an evidence-based medication for people with opioid use disorder. Clinical wisdom suggests staying on the medication consistently is important to patient outcomes. But does consistent adherence really make a difference? (Recovery Research Review)
People who inject drugs: HIV and viral hepatitis monitoring
Data tables and commentary for the unlinked anonymous monitoring surveys of infections and risk among people who inject drugs (Public Health England)
Widening the availability of naloxone
(Department of Health)
Health responses to new psychoactive substances
This short report provides an overview of the current situation in terms of NPS use and harms across Europe and reviews the available health- and drug-related interventions in that area (EMCDDA)
Delivering alcohol IBA in housing, probation and social work settings: opportunities and constraints (PDF)
Three case studies to examine the issues that arise in attempting to introduce and sustain the delivery of IBA into everyday practice in housing, probation and social work contexts (Drug and Alcohol Research Centre Middlesex University)
People who inject drugs have other priorities ahead of PrEP
With limited availability of harm reduction services, poor access to HIV treatment and little progress on legal reform, respondents suggested that people who inject drugs have more pressing needs than PrEP (aidsmap)
New Psychoactive Drugs: No Easy Answer
This paper will advance policymakers’ knowledge and thinking about this developing issue (Policy Talk)
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 24
- Next Page »